Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
BeiGene debuts $800M biologics plant set to create ‘hundreds’ of jobs in New Jersey
Fierce Pharma
Tue, 07/23/24 - 06:33 pm
BeiGene
biologics
R&D
drug manufacturing
hirings
New Jersey
FDA launches innovation hub to spur rare disease R&D
Pharmaphorum
Fri, 07/19/24 - 11:37 am
FDA
Rare Diseases
R&D
Novartis closes technical R&D site in San Diego as part of ongoing restructure
Fierce Biotech
Thu, 07/11/24 - 11:24 am
Novartis
R&D
San Diego
restructuring
Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D
BioSpace
Tue, 07/9/24 - 11:20 am
Pfizer
Mikael Dolsten
R&D
CSO
How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease
Pharma Voice
Tue, 06/18/24 - 11:34 am
Roche
biomarkers
Alzheimer's disease
Parkinson's Disease
R&D
With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy
Stat
Thu, 06/13/24 - 10:47 am
placenta-on-a-chip
R&D
pregnancy
Don’t sweat an FDA sIRB mandate in clinical research – It’s good news for everyone
Pharmaphorum
Tue, 06/11/24 - 11:18 am
FDA
sIRB
single institutional review board
R&D
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
What the rescheduling of marijuana might — and might not — mean for scientific research
Stat
Thu, 05/30/24 - 11:12 am
marijuana
Medical Marijuana
R&D
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far?
BioSpace
Fri, 05/24/24 - 11:14 am
AstraZeneca
R&D
BioMarin sheds 170 jobs in wake of narrowed R&D refocus
Fierce Biotech
Wed, 05/15/24 - 11:37 am
Biomarin
layoffs
restructuring
R&D
Chinese biotech crackdown would reset U.S. drug development
Axios
Wed, 05/15/24 - 11:25 am
China
R&D
drug development
legislation
Biosecure Act
AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh
Fierce Biotech
Mon, 05/13/24 - 10:21 pm
AbbVie
psychedelics
Gilgamesh Pharmaceuticals
R&D
Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?
BioSpace
Mon, 05/13/24 - 10:50 am
cancer
oncology
cancer vaccines
R&D
Aardvark raises $85M to target hunger, not appetite, as it contemplates IPO, pharma deals
San Diego Biotech Networks
Thu, 05/9/24 - 07:37 pm
Aardvark Therapeutics
R&D
weight loss
IPOs
funding
Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs
BioSpace
Thu, 05/9/24 - 11:43 am
Novo Nordisk
Metaphore
obesity
R&D
Rallybio reins in preclinical R&D, while Monopar pivots to radiopharma to eke out cash
Fierce Biotech
Thu, 05/9/24 - 11:32 am
Rallybio
R&D
Monopar Therapeutics
radiopharmaceuticals
AZ oncology chief says AI can help solve cancer’s ‘ZIP code lottery’ as health disparities persist
Pharma Voice
Wed, 05/8/24 - 11:25 am
AstraZeneca
oncology
artificial intelligence
R&D
AbbVie Invests €150 million in New German Development Facility
European Pharmaceutical Manufacturer
Mon, 05/6/24 - 05:58 pm
AbbVie
Germany
R&D
drug development
Quest Finds its Path to AI in Cancer Diagnostics Through M&A
Medical Devices and Diagnostics Industry
Wed, 05/1/24 - 11:13 pm
Medtech
Quest Diagnostics
diagnostics
M&A
PathAI Diagnostics
R&D
artificial intelligence
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »